文献速递其他结缔组织病

干燥综合征相关淋巴样间质性肺炎的临床病程及与其他间质性肺病模式的比较

Lymphoid interstitial pneumonia in Sjögren disease: clinical course and comparison with other ILD patterns.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

LIP患者以薄壁囊腔为主要HRCT表现,肺功能基本保留,中位随访5年全部存活且肺功能稳定。与非LIP患者相比,LIP患者诊断时更年轻,更常出现紫癜、体质症状、淋巴结肿大、高丙种球蛋白血症、三重抗Ro60/52/La阳性及C3低补体血症。

要点

  • SjD-LIP以薄壁囊腔为主,肺功能基本保留,中位5年随访稳定。
  • LIP患者更常见腺外系统受累和B细胞活化血清学标志。
  • LIP患者ILD多不先于SjD诊断,支持长期淋巴瘤监测。

核心结论

  • LIP是SjD-ILD中一种独特的免疫活跃表型,以腺外系统受累更明显和B细胞活化血清学标志为特征,但肺功能影响有限。

主要发现

  • LIP患者中位FVC 101%(IQR 98-105),DLCO 76%(IQR 75-81)。
  • 中位随访5年(IQR 2-7)所有LIP患者存活且肺功能稳定。
  • 与非LIP相比,LIP患者诊断SjD时更年轻(P < 0.001),更常见紫癜(P = 0.012)、体质症状(P = 0.001)、淋巴结肿大(P = 0.023)、高丙种球蛋白血症(P < 0.001)、三重抗Ro60/52/La阳性(P = 0.035)和C3低补体血症(P = 0.009)。
  • ILD先于SjD诊断者非LIP为30/44、LIP为1/11(P < 0.001),非LIP患者FVC%较低(P = 0.049)、DLCO%较低(P = 0.036)。

临床怎么用

  • 对SjD-LIP患者应认识其免疫活跃表型,评估腺外系统受累和B细胞活化血清学标志。
  • LIP患者肺功能影响有限且随访稳定,但仍需长期淋巴瘤监测。
  • B细胞靶向治疗可能在部分LIP患者中具有潜在作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Lymphoid interstitial pneumonia (LIP) is a rare form of Interstitial Lung Disease (ILD), often associated with Sjögren Disease (SjD). However, the clinical-serologic characteristics of SjD-LIP remain poorly characterized. Our objective was to describe the clinical course and outcome of SjD-associated LIP and to compare this subgroup with other SjD-ILD patterns. METHODS: SjD patients with High-resolution Computed Tomography (HRCT)-confirmed ILD followed in Pisa Rheumatology Unit (January 2019-November 2024) were retrospectively enrolled. ILD patterns were classified through multidisciplinary discussion. Clinical and laboratory data were collected according to ESSDAI definitions, along with pulmonary symptoms and function tests (PFTs). RESULTS: Fifty-five SjD-ILD patients were included (M: F = 9:46), of whom 11 were diagnosed with LIP (F: M = 11:0). LIP patients showed thin-walled parenchymal cysts as the predominant HRCT finding, and largely preserved pulmonary function (median forced vital capacity [FVC] 101% [IQR 98-105]; DLCO 76% [IQR 75-81]). After a median 5-years follow-up (IQR 2-7) all LIP patients were alive with stable PFTs. Compared with the remaining 44 non-LIP, LIP patients were younger at SjD diagnosis (P < 0.001) and more frequently presented purpura (P = 0.012), constitutional symptoms (P = 0.001), lymphadenopathy (P = 0.023), hypergammaglobulinemia (P < 0.001), triple anti-Ro60/52/La positivity (P = 0.035) and C3 hypocomplementemia (P = 0.009). ILD preceded SjD diagnosis in 30/44 non-LIP vs. 1/11 LIP patients (P < 0.001), with lower FVC% (P = 0.049) and DLCO% (P = 0.036) in non-LIP. CONCLUSION: LIP defines a distinct, immunologically active phenotype within the spectrum of SjD-ILD, characterized by greater extrapulmonary systemic involvement and serologic markers of B cell hyperactivity, but limited pulmonary functional impact. These findings support long-term lymphoma surveillance and a potential role for B cell targeted therapies in selected patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. La Rocca G, Ferro F, Uggenti V, et al. Lymphoid interstitial pneumonia in Sjögren disease: clinical course and comparison with other ILD patterns. Rheumatology (Oxford). 2026. PMID: 42330423. doi:10.1093/rheumatology/keag321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。